From India to the World: Naman Gosalia and AnginaX Are Taking Cardiovascular Prevention to the Global Stage<\/em><\/strong><\/p>\n

Geneva [Switzerland], May 16: <\/strong>In a proud moment for India, Naman Gosalia\u2019s consistent advocacy for making cardiovascular prevention the default, not optional, is now bringing India-born AnginaX into global healthcare and public-health conversations alongside presidents of leading cardiology societies, global healthcare leaders, policymakers, institutions, and international public-health stakeholders from across the world. <\/p>\n

His growing voice on prevention-first healthcare has led to invitations to discussions at World Heart Federation forums and broader health-policy conversations aligned with the United Nations ecosystem, where the future of cardiovascular prevention is increasingly becoming a global priority.<\/p>\n

For decades, healthcare systems around the world have largely focused on treating heart attacks after they happen.<\/p>\n

Naman Gosalia believes the future of healthcare will be defined by something far more important: preventing them before they begin. That belief is now taking India-born AnginaX onto the global stage.<\/p>\n

At a time when cardiovascular disease claims nearly 18 million lives annually worldwide, according to the World Health Organization, Gosalia has become a leading advocate for moving healthcare earlier, before symptoms, before emergencies, and before patients reach catastrophic stages of disease.<\/p>\n

As the Founder of AnginaX, he is leading a prevention-first cardiovascular model that integrates advanced medical science, precise preventive pathways, and intelligent systems into a single, continuous approach to lifelong cardiovascular health.<\/p>\n

The objective is ambitious but deeply human: to ensure people do not enter healthcare for the first time only after a crisis begins.<\/p>\n

During a recent podcast conversation on\u00a0GunjanShouts<\/em>, Gosalia summarized the philosophy behind the movement:<\/p>\n

\n
\u201cOur fight is against the disease. We don\u2019t want to save lives only at the ICU; we want to protect lives much earlier, while people are still at home.\u201d<\/strong><\/p>\n<\/blockquote>\n
His advocacy is increasingly resonating across clinicians, hospitals, policymakers, and public-health stakeholders exploring how prevention can become a continuous layer integrated into routine healthcare delivery at a real population scale.<\/p>\n
Through AnginaX, Gosalia has brought together cardiologists, physicians, scientists, researchers, engineers, and technologists around one mission: shifting healthcare from reactive treatment toward continuous cardiovascular health building.<\/p>\n
Rather than positioning prevention as occasional screening, the vision focuses on enabling earlier awareness and action before cardiovascular disease progresses toward angina, heart attack, stroke, or catastrophic events.<\/p>\n
Healthcare systems globally continue to face rising chronic disease burden, increasing emergency care costs, and overwhelmed infrastructures. In that environment, prevention is no longer being viewed as a future aspiration.<\/p>\n
It is increasingly becoming a necessity.<\/p>\n
For many across India, this represents a proud moment, an Indian-born prevention vision beginning to influence how the world approaches cardiovascular health at a population scale.<\/p>\n
And while the conversations around AnginaX continue to expand internationally, Gosalia\u2019s central message remains remarkably clear:<\/p>\n
\n
\u201cThe future of healthcare will not be defined by how well we treat heart attacks; but by how effectively we prevent them.\u201d<\/strong><\/p>\n<\/blockquote>\n
If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.<\/em><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"
From India to the World: Naman Gosalia and AnginaX Are Taking Cardiovascular Prevention to the Global Stage Geneva [Switzerland], May 16: In a proud moment for India, Naman Gosalia\u2019s consistent advocacy for making cardiovascular prevention the default, not optional, is now bringing India-born AnginaX into global healthcare and public-health conversations alongside presidents of leading cardiology…<\/p>\n
Read More “From India to the World: Naman Gosalia and AnginaX Are Taking Cardiovascular Prevention to the Global Stage”<\/span> »<\/a><\/p>\n","protected":false},"author":1,"featured_media":50229,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[639],"class_list":["post-50228","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-health"],"_links":{"self":[{"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/posts\/50228","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/comments?post=50228"}],"version-history":[{"count":0,"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/posts\/50228\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/media\/50229"}],"wp:attachment":[{"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/media?parent=50228"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/categories?post=50228"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/tags?post=50228"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}